We were pleased to hear that patients in Serbia will soon gain easy access to innovative drugs to treat some of the most difficult health conditions
We at the Japanese Business Alliance welcome the efforts that the Government and all relevant stakeholders are exerting with the aim of accelerating the pace of reforms and strengthening the stability of the business environment. On the other side, the topic of innovation is very much in the focus of the companies gathered within the Alliance. For example, the use of alternative fuels is a development opportunity in terms of bringing Serbia closer to the modern practise of countries that are already aware of the importance of ecological factors for society, which will also bring benefits to the local economy itself. Furthermore, innovations in the healthcare sector are a focal point of the Alliance, in terms of expanding the use of innovative drugs and medical devices. On that note, we were pleased to hear, during the Healthcare Panel of the Kopaonik Business Forum, that patients in Serbia will soon gain easy access to innovative drugs to treat some of the most difficult health conditions, where Japanese medicines show excellent results on the basis of real-world data.